Rhythm Pharmaceuticals (NASDAQ:RYTM) CAO Sells $502,789.84 in Stock

robot
Abstract generation in progress

Rhythm Pharmaceuticals’ CAO, Christopher Paul German, sold 5,614 shares of the company’s stock on March 4th for a total of $502,789.84, significantly reducing his ownership. Despite the sale, institutional investors like Vanguard Group Inc. and RA Capital Management L.P. have increased their holdings in RYTM. The company recently reported better-than-expected quarterly earnings but remains unprofitable, with analysts holding a “Moderate Buy” rating and an average target price of $132.07.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments